Posted on June 11: McMaster launches CELLutions Biosystems alliance

[img_inline align=”right” src=”http://padnws01.mcmaster.ca/images/cellutions.jpg” caption=”CELLutions Biosystems, Inc. launch”]McMaster launched an alliance with Toronto-based biotechnology company CELLutions Biosystems, Inc. at a luncheon this week.

Through this partnership, CELLutions will acquire the rights to market and distribute selected novel cell lines and other innovative biological reagents developed by researchers at McMaster. CELLutions focuses on the commercialization, marketing, and distribution of innovative cell lines and other research tools for use in basic science, drug discovery, and therapeutic development.

CELLutions will create and implement targeted marketing strategies to maximize the impact of these high potential technologies, and products will be made available to research groups in both the academia and biopharmaceutical industry.

“We are very pleased to enter into this alliance with CELLutions to assist McMaster in realizing new value for novel cell lines and innovative bioreagents produced by our researchers,” says Arlene Yee, industrial liaison manager.

At the launch, CELLutions representatives, McMaster technology transfer personnel and life sciences and health sciences researchers, discussed the new partnership. Pictured at the event, from left, are Michael Wasserman, CELLutions vice-president business development; Adi Treasurywala, CELLutions president and chief executive officer; Sumeet Dang, industrial liaison officer, Health Sciences; and Arlene Yee, industrial liaison manager, Health Sciences.

For further information about the partnership contact Arlene Yee at ext 26204.

Republish this Article for Free

Republish this Article

We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No Derivs 2.5 Canada (CC BY-ND 2.5 CA), so you can republish our articles for free, online or in print.

All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Daily News. Read the original article.”

[img_inline align="right" src="http://padnws01.mcmaster.ca/images/cellutions.jpg" caption="CELLutions Biosystems, Inc. launch"]McMaster launched an alliance with Toronto-based biotechnology company CELLutions Biosystems, Inc. at a luncheon this week.<p><br />
<br />
Through this partnership, CELLutions will acquire the rights to market and distribute selected novel cell lines and other innovative biological reagents developed by researchers at McMaster. CELLutions focuses on the commercialization, marketing, and distribution of innovative cell lines and other research tools for use in basic science, drug discovery, and therapeutic development.<p><br />
<br />
CELLutions will create and implement targeted marketing strategies to maximize the impact of these high potential technologies, and products will be made available to research groups in both the academia and biopharmaceutical industry.<p><br />
<br />
"We are very pleased to enter into this alliance with CELLutions to assist McMaster in realizing new value for novel cell lines and innovative bioreagents produced by our researchers," says Arlene Yee, industrial liaison manager.<p><br />
<br />
At the launch, CELLutions representatives, McMaster technology transfer personnel and life sciences and health sciences researchers, discussed the new partnership. Pictured at the event, from left, are Michael Wasserman, CELLutions vice-president business development; Adi Treasurywala, CELLutions president and chief executive officer; Sumeet Dang, industrial liaison officer, Health Sciences; and Arlene Yee, industrial liaison manager, Health Sciences.<p><br />
<br />
For further information about the partnership contact Arlene Yee at ext 26204.

Media Enquiries

Phone: (905) 525-9140 ext. 24073
Email: comms@mcmaster.ca

The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to Friday.

The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.